Drug Discovery Chemistry
About the event:
14-17 April 2025, San Diego, California
Drug Discovery Chemistry 2025 is a premier conference scheduled for April 14–17 at the Hilton Bayfront in San Diego, California. This dynamic event caters to medicinal, biophysical, and computational chemists from the pharmaceutical, biotech, and academic sectors, focusing on the discovery and optimization challenges of small molecule and macrocyclic drug candidates. The conference features over 200 presentations, including plenary keynotes by Dr. Christopher J. Helal, Vice President & Head of Medicinal Chemistry at Biogen, and Dr. Phil Baran, Chair & Professor at Scripps Research Institute. Attendees can engage in various sessions covering topics such as protein degraders, molecular glues, AI/ML for early drug discovery, and RNA-modulating small molecule drugs. With dedicated networking opportunities, interactive panel discussions, and an exhibit showcasing industry-leading sponsors, Drug Discovery Chemistry 2025 offers an ideal platform for professionals to exchange knowledge and foster collaborations in the field of drug discovery.
Taros participants:
Dr. Anil Agarwal, Head Med. Chem. 
Youri Mesmoudi, Executive Vice President
To make an appointment in advance please click on participants name or the contact button below
Are you going to attend the event? Contact us in advance to arrange a meeting
Drug Discovery Chemistry
Medicinal Chemistry
In Medicinal Chemistry research, we are working with a broadly experienced team on all biomolecular targets from any gene family in any therapeutic area…
Discovery Chemistry
Custom Synthesis
As a leading Contract Research Organization in Europe, Taros provides valuable contract discovery for synthetic organic chemistry, chemical process development, and…
